Trial · NCT00624780
Participant flow72
How many started, completed or left each group, period by period.
1 to 20 of 72
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Optimization (Up to Week 12) | STARTED | Pregabalin High Dose, Pregabalin High Dose | 154 | |
| Treatment Optimization (Up to Week 12) | STARTED | Pregabalin High Dose, Placebo | 52 | |
| Treatment Optimization (Up to Week 12) | STARTED | Pregabalin Low Dose, Pregabalin Low Dose | 154 | |
| Treatment Optimization (Up to Week 12) | STARTED | Pregabalin Low Dose, Placebo | 52 | |
| Treatment Optimization (Up to Week 12) | STARTED | Lorazepam, Lorazepam | 153 | |
| Treatment Optimization (Up to Week 12) | STARTED | Lorazepam, Placebo | 50 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Pregabalin High Dose, Pregabalin High Dose | 121 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Pregabalin High Dose, Placebo | 39 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Pregabalin Low Dose, Pregabalin Low Dose | 112 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Pregabalin Low Dose, Placebo | 38 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Lorazepam, Lorazepam | 114 | |
| Treatment Optimization (Up to Week 12) | COMPLETED | Lorazepam, Placebo | 39 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Pregabalin High Dose, Pregabalin High Dose | 33 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Pregabalin High Dose, Placebo | 13 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Pregabalin Low Dose, Pregabalin Low Dose | 42 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Pregabalin Low Dose, Placebo | 14 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Lorazepam, Lorazepam | 39 | |
| Treatment Optimization (Up to Week 12) | NOT COMPLETED | Lorazepam, Placebo | 11 | |
| Fixed Dosing (Week 13 to Week 24) | STARTED | Pregabalin High Dose, Pregabalin High Dose | 121 | |
| Fixed Dosing (Week 13 to Week 24) | STARTED | Pregabalin High Dose, Placebo | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00624780/flow